Free Trial

Rapid Micro Biosystems (RPID) Competitors

Rapid Micro Biosystems logo
$3.50 -0.05 (-1.41%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$3.46 -0.04 (-1.29%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RPID vs. EYPT, ALNT, CTKB, LAB, AEHR, SENS, QSI, MASS, QTRX, and FEIM

Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include EyePoint Pharmaceuticals (EYPT), Allient (ALNT), Cytek Biosciences (CTKB), Standard BioTools (LAB), Aehr Test Systems (AEHR), Senseonics (SENS), Quantum-Si (QSI), 908 Devices (MASS), Quanterix (QTRX), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.

Rapid Micro Biosystems vs. Its Competitors

Rapid Micro Biosystems (NASDAQ:RPID) and EyePoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Rapid Micro Biosystems has higher earnings, but lower revenue than EyePoint Pharmaceuticals. EyePoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rapid Micro Biosystems$29.65M5.17-$52.47M-$1.03-3.40
EyePoint Pharmaceuticals$56.04M10.93-$70.79M-$2.41-3.69

EyePoint Pharmaceuticals received 465 more outperform votes than Rapid Micro Biosystems when rated by MarketBeat users. Likewise, 70.40% of users gave EyePoint Pharmaceuticals an outperform vote while only 35.29% of users gave Rapid Micro Biosystems an outperform vote.

CompanyUnderperformOutperform
Rapid Micro BiosystemsOutperform Votes
6
35.29%
Underperform Votes
11
64.71%
EyePoint PharmaceuticalsOutperform Votes
471
70.40%
Underperform Votes
198
29.60%

Rapid Micro Biosystems has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, EyePoint Pharmaceuticals has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500.

Rapid Micro Biosystems currently has a consensus target price of $8.00, suggesting a potential upside of 128.57%. EyePoint Pharmaceuticals has a consensus target price of $25.38, suggesting a potential upside of 185.11%. Given EyePoint Pharmaceuticals' higher probable upside, analysts clearly believe EyePoint Pharmaceuticals is more favorable than Rapid Micro Biosystems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rapid Micro Biosystems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
EyePoint Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
3.00

Rapid Micro Biosystems has a net margin of -184.93% compared to EyePoint Pharmaceuticals' net margin of -226.57%. EyePoint Pharmaceuticals' return on equity of -43.01% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Rapid Micro Biosystems-184.93% -48.05% -39.18%
EyePoint Pharmaceuticals -226.57%-43.01%-31.63%

In the previous week, EyePoint Pharmaceuticals had 7 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 11 mentions for EyePoint Pharmaceuticals and 4 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 1.34 beat EyePoint Pharmaceuticals' score of 0.77 indicating that Rapid Micro Biosystems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rapid Micro Biosystems
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
EyePoint Pharmaceuticals
1 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 99.4% of EyePoint Pharmaceuticals shares are held by institutional investors. 30.0% of Rapid Micro Biosystems shares are held by insiders. Comparatively, 4.5% of EyePoint Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

EyePoint Pharmaceuticals beats Rapid Micro Biosystems on 11 of the 19 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPID vs. The Competition

MetricRapid Micro BiosystemsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$153.41M$4.53B$5.52B$8.60B
Dividend YieldN/A0.55%5.27%4.17%
P/E Ratio-3.1328.4326.5719.77
Price / Sales5.173.96403.66150.25
Price / CashN/A36.2938.2534.64
Price / Book1.261.677.084.68
Net Income-$52.47M-$84.30M$3.21B$247.80M
7 Day Performance-2.51%-2.53%-0.19%-0.45%
1 Month Performance9.03%9.43%7.39%3.94%
1 Year Performance348.72%-10.46%35.23%16.00%

Rapid Micro Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPID
Rapid Micro Biosystems
2.1823 of 5 stars
$3.50
-1.4%
$8.00
+128.6%
+354.5%$153.41M$29.65M-3.13200Short Interest ↓
EYPT
EyePoint Pharmaceuticals
2.2198 of 5 stars
$8.93
-0.1%
$25.38
+184.2%
-5.1%$614.48M$56.04M-4.47120
ALNT
Allient
2.5199 of 5 stars
$33.36
+4.6%
$31.00
-7.1%
+43.8%$564.75M$516.06M37.911,950
CTKB
Cytek Biosciences
2.3008 of 5 stars
$3.56
+3.5%
$5.60
+57.3%
-41.3%$435.71M$197.05M-44.49500Positive News
High Trading Volume
LAB
Standard BioTools
2.703 of 5 stars
$1.08
+1.9%
$2.50
+131.5%
-48.8%$402.61M$169.69M-1.52620Positive News
AEHR
Aehr Test Systems
3.6128 of 5 stars
$11.78
+3.9%
$25.00
+112.2%
-10.8%$350.70M$61.48M15.7190Positive News
Gap Up
SENS
Senseonics
2.4283 of 5 stars
$0.53
+0.6%
$1.55
+192.5%
+30.9%$346.73M$23.68M-4.0890Positive News
QSI
Quantum-Si
2.6818 of 5 stars
$1.71
-1.7%
$3.48
+103.2%
+29.2%$319.29M$3.44M-2.67150Positive News
MASS
908 Devices
1.9591 of 5 stars
$6.98
+0.6%
$5.33
-23.6%
+23.8%$250.31M$63.99M-3.9460Positive News
QTRX
Quanterix
3.399 of 5 stars
$5.06
-5.8%
$15.60
+208.3%
-53.7%$196.48M$133.92M-4.77460Positive News
Gap Up
FEIM
Frequency Electronics
2.2175 of 5 stars
$18.50
-3.2%
N/A+114.9%$179.02M$65.40M22.56200

Related Companies and Tools


This page (NASDAQ:RPID) was last updated on 6/17/2025 by MarketBeat.com Staff
From Our Partners